Group One Trading’s Protara Therapeutics TARA Stock Holding History

Group One Trading’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$230K	Buy	44,100 +2,200	+5%	+$13K	﹤0.01%	3997
2025 Q4	$223K	Buy	41,900 +13,800	+49%	+$76.7K	﹤0.01%	4281
2025 Q3	$122K	Sell	28,100 -5,500	-16%	-$17.8K	﹤0.01%	5152
2025 Q2	$102K	Sell	33,600 -13,600	-29%	-$46.9K	﹤0.01%	4946
2025 Q1	$201K	Buy	47,200 +35,500	+303%	+$159K	﹤0.01%	4008
2024 Q4	$61.8K	Buy	+11,700	New	+$37.8K	﹤0.01%	4896
2024 Q3	–	Sell	-200	Closed	-$416	–	7350
2024 Q2	$416	Sell	200 -900	-82%	-$2.63K	﹤0.01%	6471
2024 Q1	$4.41K	Buy	+1,100	New	+$3.55K	﹤0.01%	6239
2022 Q2	–	Sell	-1,100	Closed	-$6K	–	8508
2022 Q1	$6K	Hold	1,100	–	–	﹤0.01%	7401
2021 Q4	$7K	Sell	1,100 -500	-31%	-$3.45K	﹤0.01%	7534
2021 Q3	$11K	Buy	+1,600	New	+$12.5K	﹤0.01%	7463

Other funds holding TARA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Group One Trading's TARA Position: Q1 2026 in Review

Group One Trading reduced its Protara Therapeutics (TARA) stake by 93% in Q1 2026, selling an estimated $101K and leaving 1,297 shares worth $6.76K. The position accounts for ﹤0.01% of the portfolio, ranked #6571.

Group One Trading first reported a position in TARA in Q2 2024 and has held it in 5 quarters since. The position peaked at $98.1K in Q4 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

Group One Trading held 1,297 shares of Protara Therapeutics worth $6.76K as of Q1 2026.
Group One Trading sold 17,103 Protara Therapeutics shares in Q1 2026, an estimated $101K.
Protara Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6571 holding.
Group One Trading first reported a position in Protara Therapeutics in Q2 2024 and has held it in 5 quarters since.
Group One Trading's Protara Therapeutics position peaked at $98.1K in Q4 2025.
114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.